advertisement

Topcon

Abstract #100733 Published in IGR 23-1

Anterior Segment-Optical Coherence Tomography Bleb Morphology Comparison in Minimally Invasive Glaucoma Surgery: XEN Gel Stent vs. PreserFlo MicroShunt

Gambini G; Gambini G; Carlà MM; Carlà MM; Giannuzzi F; Boselli F; Grieco G; Caporossi T; De Vico U; Savastano A; Baldascino A; Baldascino A; Rizzo C; Rizzo C; Kilian R; Kilian R; Caporossi A; Rizzo S
Diagnostics (Basel, Switzerland) 2022; 12:


BACKGROUND: The purpose of this study is to compare the morphology of six-month follow-up blebs created by a subconjunctival glaucoma surgical device (XEN45) to those created by a PreserFlo MicroShunt with a sub-Tenon insertion, utilizing AS-OCT. METHODS: A retrospective study of 29 eyes who underwent XEN45 implantation and 29 eyes who underwent PreserFlo MicroShunt implantation. The patients were analyzed at 24 h, 1 week, 1 month, 3 months and 6 months. At each visit, the maturation and morphological alterations of the blebs were observed, as well as connections with the IOP. RESULTS: In both groups, IOP showed significant reduction at all follow ups ( < 0.0001). In XEN group, the most common bleb morphology in the immediate postoperative was the subconjuntival separation type (42%) followed by the uniform type (34%), with a trend inversion at 6 month follow up (51% of uniform type). On the contrary, the most common morphology after PreserFlo was the multiple internal layer (55%), which showed a tendency to reduce over time and was substituted by the microcystic multiform, whose percentage increased over time (17% at day 1 vs. 44% at month 6). Uniform appearance was associated by the posterior episcleral fluid (PEF) lake presence. Both horizontal and vertical diameters significantly increased over time. CONCLUSION: XEN and PreserFlo implantation resulted in the production of diffuse blebs with different characteristics, which may influence IOP lowering capacity and bleb revisions necessity over time.

Full article

Classification:

15 Miscellaneous



Issue 23-1

Change Issue


advertisement

Oculus